Eos SENOLYTIX announced that its lead drug candidate, PTC-2105, significantly reduces lean muscle mass loss associated with semaglutide treatment in aged mice, potentially improving lifespan and healthspan. Data from preclinical studies show PTC-2105 reversed muscle decline and mitigated semaglutide's negative effects on muscle mass and survival. These findings, to be presented at a major conference in December 2026, highlight PTC-2105's promise for elderly patients with sarcopenia and sarcopenic obesity. The company also plans a merger with Pulmatrix, aiming to advance clinical development and list on Nasdaq in late 2026.
Eos SENOLYTIX’s PTC-2105 and its recent data are the subject, with Pluang market data as of Nov 09, 2026 19:41 WIB for context. For readers following the Health sector, here is Pluang's market snapshot: out of 150 priced US Health-sector stocks, 121 rose and 18 fell today. Notable movers include CTXR at USD 0.54 with a -2.98% change and a typical hold time of 19 days, LQDA at USD 45.67 with a +2.86% change and a typical hold time of 4 days, and HIMS at USD 25.29 with a -2.73% change and a typical hold time of 24 days. The most notable figure is the 121 stocks that rose today in this sector.
Microsoft will retire the backend services for its UWP Map Control and Windows Maps APIs on November 30, 2026, ending map functionality in many Windows desktop and tablet applications. OnTerra Systems, a Microsoft partner, has developed an off-the-sh...
Marengo Therapeutics presented interim Phase 2 results from the STARt-002 trial combining invikafusp alfa, a selective T-cell agonist, with sacituzumab govitecan in metastatic triple-negative and HR-positive/HER2-negative breast cancer. The trial sho...
Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against The Ensign Group, Netcapital Inc., and Webull Corporation. These lawsuits allege misleading statements and failure to di...
Octave Intelligence plc has introduced Octave Attune Facilities, a cloud-based software solution designed to help organizations manage multiple sites with AI-powered tools. This platform integrates building, space, maintenance, and operational data t...
ITT Inc. reported a strong third quarter with revenue up 44% to over $1.40 billion and adjusted earnings rising 20% to $2.26 per share, driven by the SPX FLOW acquisition and 8% organic growth. Orders surged 58%, supported by aerospace, defense, and ...
